Single Shot J & J very effective against the Delta Variant

begin partial quote from:

https://www.cnn.com/2021/09/25/opinions/johnson-and-johnson-covid-19-vaccine-news-ranney/index.html

On September 16, a preprint study reported the J&J vaccine maintained its effectiveness against both symptomatic disease and hospitalization between March and the end of July -- despite the rise of the Delta variant.

This finding suggests that J&J is strongly effective against this novel variant. In other words, J&J's vaccine has staying power.

In a moment of tremendous uncertainty, this analysis allows J&J recipients to sleep easier, despite having received only a single shot.